Delivery Order SPE2DB20D9335-SPE2DB25FW3V5
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of YF-VAX 1 Dose Vials. This delivery order, valued at $2,783.55 with an ultimate completion date of August 11, 2025, was issued without a set-aside designation. The contract represents a discrete delivery against DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,783.55 by the Defense Logistics Agency on July 25, 2025, for YF-VAX 1 dose vials. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a discrete procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $2,253.96 order is for the supply of YF-VAX 1 dose vials, a yellow fever vaccine, with a period of performance through September 11, 2024. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that provides a wide range of branded and generic medications, biologics, and medical supplies to support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,817.45, is for the delivery of YF-VAX 1 dose vials and has an ultimate completion date of August 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for YF-VAX 1 dose vials with a ceiling value of $2,226.84. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 15, 2025, and will be performed at the vendor's Park Ridge location. The award falls under DMS Pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,189.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,560,800 doses of the YF-VAX yellow fever vaccine to support the recurring medical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract (IDC) with the DLA,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,113.42 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of YF-VAX 1 Dose Vials. The contract carries no set-aside designation and specifies an ultimate completion date of August 15, 2025, with performance to take place at the awardee's Park Ridge location. This delivery order is issued under DMS...
- This delivery order, valued at $11,134.20, was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 Dose Vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract carries a firm fixed-price structure with an ultimate completion date of August 11, 2025, and the place of performance is Park Ridge, Illinois. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price contract is valued at $2,817.45 and has a completion date of September 30, 2024. The contract is for the delivery of YF-VAX 1 dose vials, a yellow fever vaccine, with no set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under...
- SPE2DB20D9335Indefinite Delivery Contract
- SPE2DB20D9335-SPE2DB25FW3V5Delivery Order
The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 21, 2025, for the supply of YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under DMS's existing $499.999 billion Indefinite Delivery Contract with DLA through the SPE2DB program, which remains valid through November 2026 and enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities. YF-VAX is a yellow fever vaccine critical to military medical readiness and personnel deployment support. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, consistently delivering vaccines, medications, and medical consumables to Department of Defense healthcare facilities nationwide. The company's positioning as a reliable federal contractor for pharmaceutical distribution, combined with its woman-owned small business status, has enabled it to secure multiple delivery orders under the DLA's SPE2DB program for diverse medical products ranging from vaccines to specialty pharmaceuticals and biologics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.8k | 7/21/25 |